MUFG Securities EMEA plc

Broker-Dealer

Position in ABBV — AbbVie Inc.

CIK 1597694 LONDON, X0

Position in ABBV

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$94,052,463

+$77,499,505 QoQ

Shares Held

432,445

+496.9% QoQ

Ownership

0.024%

of shares outstanding

% of Portfolio

1.43%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MUFG Securities EMEA plc holds $423,932,325 across 10 Drug Manufacturers - General names. ABBV ranks #2 (22.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	863,980	$170,394,135
2	ABBV	AbbVie Inc. This page	432,445	$94,052,463
3	GILD	Gilead Sciences, Inc.	521,862	$72,731,906
4	LLY	ELI LILLY & Co	32,487	$29,880,567
5	JNJ	Johnson & Johnson	98,798	$24,150,183
6	MRK	Merck & Co., Inc.	101,752	$12,239,748
7	AMGN	Amgen Inc	22,085	$7,770,607
8	PFE	Pfizer Inc	233,159	$6,547,104

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$94,052,463	432,445	+496.9%	Shares	Defined	2026-05-11
2025-12-31	$16,552,958	72,445	+114.3%	Shares	Defined	2026-02-10
2025-09-30	$7,829,062	33,813	-77.5%	Shares	Sole	2025-11-14
2024-06-30	$25,727,828	149,999	+7.1%	Shares	Sole	2024-07-31
2023-12-31	$21,695,800	140,000	-5.8%	Shares	Sole	2024-02-12
2023-06-30	$20,029,635	148,665	+161492.4%	Shares	Sole	2023-08-03
2022-03-31	$14,914	92	-88.5%	Shares	Sole	2022-05-18
2021-12-31	$108,590	802	-99.7%	Shares	Sole	2022-02-11
2021-09-30	$26,514,446	245,800	-49.4%	Shares	Sole	2021-11-12
2021-06-30	$54,664,192	485,300	+101.2%	Shares	Sole	2021-07-19
2021-03-31	$26,100,391	241,179	-55.7%	Shares	Sole	2021-05-11
2020-12-31	$58,396,750	545,000	+180.3%	Shares	Sole	2021-02-11
2020-09-30	$17,031,349	194,444	-60.8%	Shares	Sole	2020-11-13
2020-06-30	$48,701,599	496,044	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.